Key Process Parameters to Optimize Drug-Based Coatings on Stents & Balloons Using UMC7300 Ultrasonic Coating Equipment

Developing a drug coating for a cardiovascular device is a process-development exercise, not simply a matter of applying liquid to a surface. An Ultrasonic Balloon Catheter Coating System such as the UMC7300 can be considered as a laboratory platform for investigating controlled deposition on balloon-catheter and coronary-stent surfaces. The useful process window must be established experimentally for each formulation, substrate and target coating profile.

Paclitaxel-based balloon coatings and limus-based coronary-stent coatings can have different formulation and performance requirements. For that reason, teams should avoid assuming that settings developed for one drug, solvent system or device geometry can be transferred directly to another.

Start with a defined experimental plan

Before changing equipment settings, define the response you want to measure. Examples include coverage of the intended area, visible defects, coating distribution, drug loading, adhesion or integrity after a relevant handling step. Choose methods that are appropriate to the device and formulation, and set acceptance criteria before comparing samples.

1. Formulation properties

Composition, concentration, viscosity, surface tension, solvent choice and suspension stability can affect atomisation and wetting. Record preparation and storage conditions, and assess whether the formulation remains consistent throughout a trial. Drug and excipient compatibility should be evaluated by qualified formulation specialists.

2. Atomisation and liquid delivery

Investigate the equipment’s available atomisation and liquid-delivery controls within its documented operating guidance. Changes can influence droplet formation, deposition and overspray. Do not infer a specific droplet size, output rate or accuracy without measurement and equipment documentation. Change one factor at a time during initial screening when practical.

3. Nozzle-to-part relationship and motion

Working distance, orientation, spray path, traverse speed and the way a part is held can affect where material lands. Stent struts and balloon folds create different geometric challenges. A fixture that gives repeatable positioning can help reduce variation between runs; its suitability should be verified for each device format.

4. Drying and environmental conditions

Evaporation behaviour depends on formulation, ambient conditions, airflow and the timing of successive coating passes. Too much or too little time between passes may change film formation or cause local accumulation. Record relevant environmental conditions and use the laboratory’s approved solvent-safety procedures.

5. Substrate preparation and handling

Surface condition, cleanliness, material composition and prior processing can affect wetting and adhesion. Establish a consistent preparation method and document any treatment. Handling after coating—including folding, expansion or other device-specific steps—may reveal issues that are not visible on an untouched sample.

A disciplined optimization workflow

1. Document the baseline formulation, substrate, equipment setup and sample identification.
2. Screen a small number of factors using a structured plan rather than changing many variables at once.
3. Use suitable imaging and analytical tests to assess the chosen responses.
4. Repeat promising conditions to understand variability and identify interactions.
5. Record unsuccessful as well as successful runs, then confirm the selected window on representative samples.

See Cheersonic’s ultrasonic drug balloon coating machine information and the overview of ultrasonic atomizing coating.

Keep process development separate from validation

A repeatable laboratory result is a useful milestone, but it does not by itself demonstrate product safety, clinical performance or regulatory compliance. Scale-up, process validation, stability, sterilisation compatibility, biocompatibility and other assessments should be planned according to the device and its intended use.

Frequently asked questions

1. Which parameter should be optimized first?

Begin with the factor most likely to influence your primary measured response, based on formulation knowledge and preliminary trials. There is no single first parameter that suits every device.

2. Can settings for a balloon be reused for a stent?

Use them only as a starting hypothesis if technically justified. Different geometries and target surfaces require separate screening and confirmation.

3. How can coating uniformity be assessed?

Use a defined sampling plan and suitable methods such as microscopy, image analysis or validated chemical analysis, depending on the attribute being assessed. Visual inspection alone may not be sufficient.

4. Should several process factors be changed together?

Structured experimental design can evaluate multiple factors efficiently, but the plan and analysis should be chosen deliberately. Unrecorded simultaneous changes make cause and effect difficult to interpret.

Discuss your coating-development project

Qualified medical-device manufacturers, R&D teams and production engineers can contact Cheersonic to discuss their medical-device coating project and arrange a sample coating test. Email market2@cheersonic.com with your device type, formulation-development goals and the coating attributes you plan to evaluate.